Deciphera Pharmaceuticals

+$0.13 (+1.10%) As of 11:01 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DCPH and other ETFs, options, and stocks.

About DCPH

Deciphera Pharmaceuticals, Inc. engages in discovering, developing, and delivering important new medicines to patients for the treatment of cancer. The firm designs a drug candidate, DCC-2618, to inhibit the full spectrum of mutant or amplified KIT and PDGFRa kinases that drive cancers such as gastrointestinal stromal tumors (GIST), advanced systemic mastocytosis (ASM), gliomas, and other solid tumors.

CEO
Steven L. Hoerter
Employees
280
Headquarters
Waltham, Massachusetts
Founded
2003

DCPH Key Statistics

Market cap
784.00M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.21M
High today
$11.87
Low today
$11.04
Open price
$11.46
Volume
1.07M
52 Week high
$38.91
52 Week low
$6.51

DCPH Earnings

-$1.51
-$1.01
-$0.50
-$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure